Cash Flow Statement
Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Account Payables (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Change in Account Payables over the past 16 years, most recently at $1.0 million for Q2 2025.

  • For Q2 2025, Change in Account Payables rose 150.7% year-over-year to $1.0 million; the TTM value through May 2025 reached -$1.7 million, up 74.99%, while the annual FY2025 figure was -$1.7 million, 74.99% up from the prior year.
  • Change in Account Payables for Q2 2025 was $1.0 million at Lifecore Biomedical, Inc. \De\, up from -$3.5 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $13.7 million in Q4 2021 and troughed at -$12.4 million in Q2 2021.
  • A 5-year average of $614055.6 and a median of -$207500.0 in 2023 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: surged 1592.15% in 2021 and later tumbled 4708.47% in 2024.
  • Year by year, Change in Account Payables stood at $13.7 million in 2021, then decreased by 18.67% to $11.1 million in 2022, then crashed by 100.53% to -$59000.0 in 2023, then tumbled by 4708.47% to -$2.8 million in 2024, then soared by 136.8% to $1.0 million in 2025.
  • Business Quant data shows Change in Account Payables for LFCR at $1.0 million in Q2 2025, -$3.5 million in Q1 2025, and -$2.8 million in Q4 2024.